Precision BioSciences Inc. (DTIL) PT Lowered to $16 at Stifel, Maintained at Buy, Analyst Remains Bullish into Expected CD19-CAR-T Data
Tweet Send to a Friend
Stifel analyst Benjamin J. Burnett lowered the price target on Precision BioSciences Inc. (NASDAQ: DTIL) to $16.00 (from $24.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
